PPA
NTLA icon

Parametric Portfolio Associates’s Intellia Therapeutics NTLA Stock Holding History

Parametric Portfolio Associates’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.85M Sell
39,164
-20,650
-35% -$1.75M ﹤0.01% 2226
2021
Q4 		$7.07M Sell
59,814
-21,717
-27% -$2.72M ﹤0.01% 1629
2021
Q3 		$10.9M Buy
81,531
+15,659
+24% +$2.37M 0.01% 1291
2021
Q2 		$10.7M Buy
65,872
+38,365
+139% +$2.99M 0.01% 1337
2021
Q1 		$2.21M Buy
27,507
+6,500
+31% +$436K ﹤0.01% 2719
2020
Q4 		$1.14M Buy
21,007
+3,438
+20% +$125K ﹤0.01% 2975
2020
Q3 		$349K Buy
17,569
+693
+4% +$14.4K ﹤0.01% 3427
2020
Q2 		$355K Sell
16,876
-1,924
-10% -$32.7K ﹤0.01% 3403
2020
Q1 		$230K Sell
18,800
-29,881
-61% -$403K ﹤0.01% 3492
2019
Q4 		$714K Buy
48,681
+35,418
+267% +$493K ﹤0.01% 3223
2019
Q3 		$177K Buy
13,263
+543
+4% +$8.66K ﹤0.01% 3736
2019
Q2 		$208K Sell
12,720
-2,953
-19% -$46.4K ﹤0.01% 3732
2019
Q1 		$268K Buy
+15,673
New +$234K ﹤0.01% 3596
2018
Q4 		– Sell
-14,466
Closed -$414K – 3940
2018
Q3 		$414K Buy
14,466
+2,359
+19% +$68.6K ﹤0.01% 3503
2018
Q2 		$331K Buy
+12,107
New +$293K ﹤0.01% 3518

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Parametric Portfolio Associates's NTLA Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Intellia Therapeutics (NTLA) stake by 35% in Q1 2022, selling an estimated $1.75M and leaving 39,164 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2226.

Parametric Portfolio Associates first reported a position in NTLA in Q2 2018 and has held it in 15 quarters since. The position peaked at $10.9M in Q3 2021. 349 funds tracked by Wall St. Rank hold NTLA as of Q1 2022.

  • Parametric Portfolio Associates held 39,164 shares of Intellia Therapeutics worth $2.85M as of Q1 2022.
  • Parametric Portfolio Associates sold 20,650 Intellia Therapeutics shares in Q1 2022, an estimated $1.75M.
  • Intellia Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2226 holding.
  • Parametric Portfolio Associates first reported a position in Intellia Therapeutics in Q2 2018 and has held it in 15 quarters since.
  • Parametric Portfolio Associates's Intellia Therapeutics position peaked at $10.9M in Q3 2021.
  • 349 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.